Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Other Non-Current Liabilities (2023 - 2025)

Historic Other Non-Current Liabilities for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $1.2 million.

  • Beta Bionics' Other Non-Current Liabilities changed N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $44.9 million for FY2024, which is 1949.54% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Other Non-Current Liabilities is $1.2 million.
  • In the past 5 years, Beta Bionics' Other Non-Current Liabilities ranged from a high of $44.9 million in Q4 2024 and a low of $400000.0 during Q1 2025
  • In the last 3 years, Beta Bionics' Other Non-Current Liabilities had a median value of $1.2 million in 2025 and averaged $17.0 million.
  • The largest annual percentage gain for Beta Bionics' Other Non-Current Liabilities in the last 5 years was 1949.54% (2024), contrasted with its biggest fall of 1949.54% (2024).
  • Quarter analysis of 3 years shows Beta Bionics' Other Non-Current Liabilities stood at $37.6 million in 2023, then increased by 19.5% to $44.9 million in 2024, then crashed by 97.32% to $1.2 million in 2025.
  • Its Other Non-Current Liabilities was $1.2 million in Q3 2025, compared to $1.0 million in Q2 2025 and $400000.0 in Q1 2025.